Observational Study
Copyright ©The Author(s) 2019.
World J Gastroenterol. Aug 7, 2019; 25(29): 4007-4018
Published online Aug 7, 2019. doi: 10.3748/wjg.v25.i29.4007
Table 5 Curative treatments for dermatological toxicities (Primary analysis set, n = 229)
Day 15 (n = 214)Month 1 (n = 208)Month 2 (n = 186)Month 3 (n = 153)Month 4 (n = 122)Month 5 (n = 93)Month 6 (n = 87)
At least one curative treatment, n (%)117/214 (54.7)124/208 (59.6)118/186 (63.4)92/153 (60.1)63/120 (52.5)47/92 (51.1)39/87 (44.8)
Emollients74 (63.2)82 (66.1)84 (71.2)69 (75.0)45 (71.4)29 (61.7)24 (61.5)
Oral antibiotics88 (75.2)90 (72.6)88 (74.6)65 (70.7)43 (68.3)31 (66.0)28 (71.8)
Emollients and oral antibiotics60 (51.3)61 (49.2)61 (51.7)47 (51.1)28 (44.4)17 (36.2)16 (41.0)
Antiseptics9 (7.8)7 (5.6)11 (9.3)7 (7.6)2 (3.2)1 (2.1)0 (0.0)
Antihistamines12 (10.3)10 (8.1)11 (9.4)10 (10.9)6 (9.5)5 (10.6)2 (5.1)
Corticosteroids19 (16.2)26 (21.0)23 (19.5)19 (20.7)12 (19.0)6 (12.8)9 (23.1)
Other (including topical antibiotics)51 (44.0)47 (37.9)35 (29.7)29 (31.9)20 (31.7)16 (34.0)13 (33.3)
Topical antibiotics48 (94.1)43 (91.5)30 (85.7)25 (86.2)18 (90.0)16 (100)13 (100)